Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bagriaçik, E.
Right arrow Articles by Miller, K. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bagriaçik, E.
Right arrow Articles by Miller, K. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Glycobiology, Vol 9, 267-275, Copyright © 1999 by Oxford University Press


ORIGINAL ARTICLES

Cell surface sialic acid and the regulation of immune cell interactions: the neuraminidase effect reconsidered

E Ümit Bagriaçik and KS Miller
Faculty of Biological Science and The Mervin Bovaird Center for Studies in Molecular Biology and Biotechnology, The University of Tulsa, Tulsa,OK 74104, USA.

It has been known for over a decade that sialidase (neuraminidase) treatment could substantially enhance the capacity of resting B cells to stimulate the proliferation of allogeneic and antigen specific, syngeneic T cells. Thus, cell-surface sialic acid was implicated as a potential modulator of immune cell interaction. However, little progress has been made in either identifying explicit roles for sialic acid in this system or in hypothesizing mechanisms to explain the "neuraminidase effect." Here we show for the first time that cell surface sialic acid on medium incubated B cells blocks access to costimulatory molecules on the B cell surface, and that this is the most likely explanation for the neuraminidase effect. Further, we show that it is likely to be upregulation of ICAM-1 and its subsequent engagement of LFA-1 rather than loss of cell surface sialic acid that in part regulates access to CD86 and other costimulatory molecules. However, we cannot exclude a role for CD86-bound sialic acid on the B cell in modulating binding to T cell CD28. Because sialidase treatment of resting B cells but not resting T cells enables T cell activation, we suggest that sialidase treatment may still be an analogue for an authentic step in B cell activation, and show that for highly activated B cells (activated with polyclonal anti-IgM plus INF-gamma) there is specific loss 2, 6-linked sialic acid. Potential roles for sialic acid in modulating B cell/T cell collaboration are discussed.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
X. Nan, I. Carubelli, and N. M. Stamatos
Sialidase expression in activated human T lymphocytes influences production of IFN-{gamma}
J. Leukoc. Biol., January 1, 2007; 81(1): 284 - 296.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
E. Ish-Shalom, A. Gargir, S. Andre, Z. Borovsky, Z. Ochanuna, H.-J. Gabius, M. L. Tykocinski, and J. Rachmilewitz
{alpha}2,6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells
Glycobiology, March 1, 2006; 16(3): 173 - 183.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. I. Yudin, S. E. Generao, T. L. Tollner, C. A. Treece, J. W. Overstreet, and G. N. Cherr
Beta-Defensin 126 on the Cell Surface Protects Sperm from Immunorecognition and Binding of Anti-Sperm Antibodies
Biol Reprod, December 1, 2005; 73(6): 1243 - 1252.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. H. Marino, M. Hoffman, M. Meyer, and K. S. Miller
Sialyltransferase mRNA abundances in B cells are strictly controlled, correlated with cognate lectin binding, and differentially responsive to immune signaling in vitro
Glycobiology, December 1, 2004; 14(12): 1265 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
C.-P. Danzer, B. E. Collins, O. Blixt, J. C. Paulson, and L. Nitschke
Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling
Int. Immunol., October 1, 2003; 15(10): 1137 - 1147.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
R Wiggins, S J Hicks, P W Soothill, M R Millar, and A P Corfield
Mucinases and sialidases: their role in the pathogenesis of sexually transmitted infections in the female genital tract
Sex Transm Inf, December 1, 2001; 77(6): 402 - 408.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
X.-Q. Wang, P. Sun, M. O'Gorman, T. Tai, and A. S. Paller
Epidermal growth factor receptor glycosylation is required for ganglioside GM3 binding and GM3-mediated suppresion of activation
Glycobiology, July 1, 2001; 11(7): 515 - 522.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. U. Bagriacik, M. D. Armstrong, M. Okabe, and J. R. Klein
Differential expression of CD43 isoforms on murine T cells and their relationship to acute intestinal graft versus host disease: studies using enhanced-green fluorescent protein transgenic mice
Int. Immunol., October 1, 1999; 11(10): 1651 - 1662.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.